Veterinary Medicines

HIPRAVIAR-TRT4

Authorised
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
  • Avian infectious bronchitis virus, strain H52, Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
Download as PDF

Product identification

Medicine name:
HIPRAVIAR-TRT4
Active substance:
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
  • Avian infectious bronchitis virus, strain H52, Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
    6.00
    log10 (50% tissue culture infectious dose)/dose
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, strain H52, Inactivated
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain La Sota, Inactivated
    819.00
    haemagglutinating units
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2434/09.12.2014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/06/2022
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/06/2022
Download